Abstract:There are no vaccines licensed for enterotoxigenic Escherichia coli (ETEC), a leading cause of diarrhea for children in developing countries and international travelers. Virulence heterogeneity among strains and difficulties identifying safe antigens for protective antibodies against STa, a potent but poorly immunogenic heat-stable toxin which plays a key role in ETEC diarrhea, are challenges in ETEC vaccine development. To overcome these challenges, we applied a toxoid fusion strategy and a novel epitope- and structure-based multiepitope fusion antigen (MEFA) vaccinology platform to construct two chimeric multivalent proteins, toxoid fusion 3xSTaN(12S)-mnLT(R192G/L211A) and adhesin CFA/I/II/IV MEFA, and demonstrated that the proteins induced protective antibodies against STa and heat-labile toxin (LT) produced by all ETEC strains or the seven most important ETEC adhesins (CFA/I and CS1 to CS6) expressed by the ETEC strains causing 60 to 70% of diarrheal cases and moderate to severe cases. Combining two proteins, we prepared a protein-based multivalent ETEC vaccine, MecVax. MecVax was broadly immunogenic; mice and pigs intramuscularly immunized with MecVax developed no apparent adverse effects but had robust antibody responses to the target toxins and adhesins. Importantly, MecVax-induced antibodies were broadly protective, demonstrated by significant adherence inhibition against E. coli bacteria producing any of the seven adhesins and neutralization of STa and cholera toxin (CT) enterotoxicity. Moreover, MecVax protected against watery diarrhea and provided over 70% and 90% protection against any diarrhea from an STa-positive or an LT-positive ETEC strain in a pig challenge model. These results indicated that MecVax induces broadly protective antibodies and prevents diarrhea preclinically, signifying that MecVax is potentially an effective injectable vaccine for ETEC. IMPORTANCE Enterotoxigenic Escherichia coli (ETEC) bacteria are a top cause of children's diarrhea and travelers' diarrhea and are responsible for over 220 million diarrheal cases and more than 100,000 deaths annually. A safe and effective ETEC vaccine can significantly improve public health, particularly in developing countries. Data from this preclinical study showed that MecVax induces broadly protective antiadhesin and antitoxin antibodies, becoming the first ETEC vaccine candidate to induce protective antibodies inhibiting adherence of the seven most important ETEC adhesins and neutralizing the enterotoxicity of not only LT but also STa toxin. More importantly, MecVax is shown to protect against clinical diarrhea from STa-positive or LT-positive ETEC infection in a pig challenge model, recording protection from antibodies induced by the protein-based, injectable, subunit vaccine MecVax against ETEC diarrhea and perhaps the possibility of intramuscularly administered protein vaccines for protection against intestinal mucosal infection.

Fusion Expression and Immunogenicity of EHEC EspA-Stx2Al Protein: Implications for the Vaccine Development

Expression of Fusion Protein Stx2B-Tir-Stx1B from Enterohemorrhagic Escherichia Coli O157: H7 and Its Immunogenicity Analysis in BALB/c Mice

Enterohemorrhagic Escherichia Coli Trivalent Recombinant Vaccine Containing EspA, Intimin and Stx2 Induces Strong Humoral Immune Response and Confers Protection in Mice.

Enhanced Immunogenicity of A Novel Stx2am-Stx1b Fusion Protein in A Mice Model of Enterohemorrhagic Escherichia Coli O157:H7 Infection

Recombinant Expressing and Protective Immunity of EspA and Es-pB from Enterohemorrhagic E.coli O157∶H7

Mo1948 Toward a Broadly Protective Vaccine Against Enterotoxigenic E.coli (ETEC) Infections

The Immunogenicity of Fusion Protein Linking the Carboxyl Terminus of the B Subunit of Shiga Toxin 2 to the B Subunit of E. Coli Heat-Labile Enterotoxin.

Immunogenicity Characterization of Genetically Fused or Chemically Conjugated Heat-Stable Toxin Toxoids of Enterotoxigenic Escherichia Coli in Mice and Pigs.

The Fusion and Expression of Genes Encoding Subunit B of Shiga-like Toxin Type 2 Variant and Subunit B of Escherichia Coli Heat-Labile Enterotoxins from Porcine Origin

Construction and Expression of Stx2eb-Ltb-st Fusion Gene

Genetic Fusions of Heat-Labile Toxoid (lt) and Heat-Stable Toxin B (stb) of Porcine Enterotoxigenic Escherichia Coli Elicit Protective Anti-Lt and Anti-Stb Antibodies

Secretion of the Shiga toxin B subunit (Stx1B) via an autotransporter protein optimizes the protective immune response to the antigen expressed in an attenuated E. coli (rEPEC E22Δler) vaccine strain

Expression of fusion protein CTB-mST2 in E. Coli and its bioactivity assay

Prokaryotic expression of Stx1B subunit of Escherichia coli O157:H7 used to generate monoclonal antibody.

Co-administered Tag-Less Toxoid Fusion 3Xsta(n1)(2s)-Mnlt(r192g/l211a) and CFA/I/II/IV MEFA (multiepitope Fusion Antigen) Induce Neutralizing Antibodies to 7 Adhesins (CFA/I, CS1-CS6) and Both Enterotoxins (LT, STa) of Enterotoxigenic Escherichia Coli (ETEC)

A novel Salmonella strain inactivated by a regulated autolysis system and expressing the B subunit of Shiga toxin 2e efficiently elicits immune responses and confers protection against virulent Stx2e-producing Escherichia coli

Characterization of Heat-Stable (sta) Toxoids of Enterotoxigenic Escherichia Coli Fused to Double Mutant Heat-Labile Toxin Peptide in Inducing Neutralizing Anti-STa Antibodies.

EspA is a Novel Fusion Partner for Expression of Foreign Proteins in Escherichia Coli

Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate

Enterotoxigenic Escherichia Coli Heat-Stable Toxin and Heat-Labile Toxin Toxoid Fusion 3Xstan12s-Dmlt Induces Neutralizing Anti-Sta Antibodies in Subcutaneously Immunized Mice.

Construction and characterization of EHEC 0157△ler/stx(pBR322::stx 1/2B::eae)